
Brecon appoints Nycomed’s Dr Herbert Pomper
pharmafile | June 14, 2010 | Appointment | Manufacturing and Production | Brecon, appointment, manufacturing and production
Packaging and clinical supply services company Brecon Pharmaceuticals has appointed Dr Herbert Pomper to the newly created role of associate director, European business development.
Dr Pomper joins Brecon from Nycomed Austria, where he was latterly associate director, global contract manufacturing.
He began his pharma career in 1994 and has worked for a number of national and multinational companies, including Fresenius Kabi, where he held senior positions covering disciplines including R&D, formulation development and documentation.
Based in Graz, Austria, Dr Pomper will manage and develop Brecon’s relationships with its client base in the European pharma heartland, comprising Germany, France and Switzerland.
He will also be responsible for burgeoning markets such as Spain, Portugal and Eastern Europe.
Related Content

Rotzinger launches modular filling and capping platform for over-the-counter products
Rotzinger PharmaPack has launched a new filling and capping platform called VarioFill, designed to handle …

David Wheadon appointed to board of directors at Seaport Therapeutics
This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

Myeloma UK reveals new Director of Research appointment
UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …






